Procter & Gamble Company (The) PG
146.23
0.55
0.38%
as of 25 Sep
- Market cap
- $338.8B
- P/E
- 21.6×
Follow PG
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Procter & Gamble Company (The) (PG) EBITDA
Procter & Gamble Company (The)'s EBITDA for fiscal 2026 was $22.9B, unchanged from fiscal 2025. Over the past ten years it has ranged from $8.3B (fiscal 2019) to $23.3B (fiscal 2025); the current reading is higher than 92% of that period. Procter & Gamble Company (The) ranks 2nd of 30 Household & Personal Products companies by EBITDA.
EBITDA, annual
Annual
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $22.9B | (1.67%) |
| FY2025 | $23.3B | 8.66% |
| FY2024 | $21.4B | 2.84% |
| FY2023 | $20.8B | 1.11% |
| FY2022 | $20.6B | (0.49%) |
| FY2021 | $20.7B | 10.70% |
| FY2020 | $18.7B | 125.23% |
| FY2019 | $8.3B | (48.69%) |
| FY2018 | $16.2B | (2.35%) |
| FY2017 | $16.6B | 0.41% |
Quarterly
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $4.8B | (11.21%) |
| Mar 2026 | $5.4B | (13.07%) |
| Dec 2025 | $6.2B | (6.79%) |
| Sep 2025 | $6.6B | 30.31% |
| 42 more quarters | Free account |
Against its own ten years
Low $8.3B
High $23.3B
Ten-year median
$19.7B
Current reading's percentile
92
EBITDA against peers
| Company | EBITDA |
|---|---|
| UL Unilever PLC compare | $25.1B |
| PG Procter & Gamble Company (The) | $22.9B |
| CL Colgate-Palmolive Company compare | $4.7B |
| KMB Kimberly-Clark Corporation compare | $3.2B |
| KVUE Kenvue Inc. compare | $3.2B |
| EL The Estee Lauder Companies Inc. compare | $1.6B |
| CHD Church & Dwight Co., Inc. compare | $1.3B |
| CLX The Clorox Company compare | $1.2B |
| ELF e.l.f. Beauty compare | $221.4M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on PG
- Revenue
- Net income
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement